What is USANA Health Sciences's rise — net sales?

USANA Health Sciences (USNA) reported rise — net sales of $13.67M in Q1 2026.

What does rise — net sales mean?

Represents the total revenue generated from the Rise product line or business segment before the deduction of any expenses. This metric tracks the market demand and sales performance specifically attributable to this segment within the company's broader nutritional and personal-care portfolio.

USANA Health Sciences (USNA) Rise — Net Sales

Screener

Other segment segments

Core Nutritional

$204.4M—

Hiya

$32.15M-13.3%

Similar metrics at other companies

CENTPet — Net Sales

$400.5M-18.7%

CNHNet Sales — Net Sales

$2.6B+0.6%

GISPet — Net Sales

$746.6M+5.8%

CLPet Nutrition — Net Sales

$1.2B—

OTISNew Equipment — Net Sales

$1.28B+0.2%

WNCNew trailers — Net Sales

$317.05M+1.6%

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$264.76M-50.6%

P/E13.2×+5.7×

P/S0.3×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.

Filed: May 12, 2026, 4:35 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q2 2026
Accession: 0000896264-26-000034

Line item	Core Nutritional	Hiya	Rise	Total
Net sales (1)	$204,399	$32,150	$13,669	$250,218
Less:
Cost of sales	36,749	9,983	12,704	59,436
Brand Partner incentives	88,654	—	—	88,654
Selling, general and administrative (2)	60,747	24,771	2,736	88,254
Segment earnings (loss) from operations	$18,249	$(2,604)	$(1,771)	$13,874
Reconciliation of segment earnings from operations
Interest income				437

Item 1. FINANCIAL STATEMENTS

FAQ

What is USANA Health Sciences's rise — net sales?: USANA Health Sciences (USNA) reported rise — net sales of $13.67M in Q1 2026.
What does rise — net sales mean?: Represents the total revenue generated from the Rise product line or business segment before the deduction of any expenses. This metric tracks the market demand and sales performance specifically attributable to this segment within the company's broader nutritional and personal-care portfolio.